3.0.0 1862 2019-11-15T21:21:17Z 2019-11-15T21:21:17Z House H HR 2011-05-12 112 From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. BILBRAY:H.R. 1862.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3 of the United StatesConstitution and Article I, Section 8, Clause 18 of theUnited States Constitution.[Page H3280]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2011-05-13T18:50:26Z Referred to 2011-05-12T14:00:41Z 2011-05-13 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2011-05-12 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2011-05-12 Introduced in House IntroReferral Intro-H 9 Library of Congress 2011-05-12 Introduced in House IntroReferral 1000 9 Library of Congress B000461 Rep. Bilbray, Brian P. [R-CA-50] BRIAN BILBRAY R CA P. 50 N D000197 Rep. DeGette, Diana [D-CO-1] DIANA DEGETTE D CO 1 2011-05-12 True D000604 Rep. Dent, Charles W. [R-PA-15] Charles Dent R PA W. 15 2011-05-12 True G000549 Rep. Gerlach, Jim [R-PA-6] Jim Gerlach R PA 6 2011-05-12 True H001032 Rep. Holt, Rush [D-NJ-12] RUSH HOLT D NJ D. 12 2011-05-12 True F000455 Rep. Fudge, Marcia L. [D-OH-11] Marcia Fudge D OH L. 11 2011-05-12 True B001251 Rep. Butterfield, G. K. [D-NC-1] G. K. Butterfield D NC 1 2011-05-12 True L000559 Rep. Langevin, James R. [D-RI-2] JAMES LANGEVIN D RI R. 2 2011-05-12 True E000215 Rep. Eshoo, Anna G. [D-CA-14] ANNA ESHOO D CA G. 14 2011-06-02 False C001037 Rep. Capuano, Michael E. [D-MA-8] MICHAEL CAPUANO D MA E. 8 2011-06-21 False L000553 Rep. LaTourette, Steven C. [R-OH-14] STEVEN LATOURETTE R OH C. 14 2011-06-21 False F000030 Rep. Farr, Sam [D-CA-17] SAM FARR D CA 17 2011-09-21 False F000339 Rep. Frank, Barney [D-MA-4] BARNEY FRANK D MA 4 2011-10-06 False M000312 Rep. McGovern, James P. [D-MA-3] JAMES MCGOVERN D MA P. 3 2011-10-06 False J000283 Rep. Jackson, Jesse L., Jr. [D-IL-2] JESSE JACKSON D IL L. 2 2011-10-06 False B001248 Rep. Burgess, Michael C. [R-TX-26] Michael Burgess R TX C. 26 2011-12-14 False R000462 Rep. Rothman, Steven R. [D-NJ-9] STEVEN ROTHMAN D NJ R. 9 2012-04-17 False D000610 Rep. Deutch, Theodore E. [D-FL-19] Theodore Deutch D FL E. 19 2012-04-25 False M001169 Rep. Murphy, Christopher [D-CT-5] Christopher Murphy D CT S. 5 2012-05-07 False V000128 Rep. Van Hollen, Chris [D-MD-8] Chris Van Hollen D MD 8 2012-11-13 False Health Advisory bodies Department of Health and Human Services Drug safety, medical device, and laboratory regulation Executive agency funding and structure Genetics Health programs administration and funding Health technology, devices, supplies Medical research Product development and innovation Research administration and funding Research and development Health 00 2011-05-12 Introduced in House 2011-06-28T17:59:16Z Regenerative Medicine Promotion Act of 2011 - Requires the Comptroller General to submit to Congress a report identifying all ongoing federal programs and activities regarding regenerative medicine.

Directs the Secretary of Health and Human Services (HHS) to establish a Regenerative Medicine Coordinating Council in the Office of the Secretary, the duties of which shall include: (1) preparing a national strategy to support research into regenerative medicine and the development of drugs, biological products, medical devices, and biomaterials for use in regenerative medicine; (2) identifying sources of funding for research into regenerative medicine and areas where such funding is inadequate; and (3) making recommendations regarding federal policies to support development and marketing of regenerative medicine products.

Authorizes the Secretary, acting through the Director of the National Institutes of Health (NIH), to make grants for: (1) basic or preclinical research into regenerative medicine; (2) research and development of drugs, biological products, medical devices, and biomaterials for use in regenerative medicine; and (3) the making of an investigational new drug application or an investigational device exemption application within four years of receiving such grant.

Amends the Public Health Service Act to authorize the Director of NIH to award grants, contracts, or cooperative agreements to accelerate the development of high need cures through the development of medical products and behavioral therapies for use in regenerative medicine.

Authorizes the Secretary, acting through the Commissioner of Food and Drugs, to: (1) conduct, support, or collaborate in regulatory research to assist the Food and Drug Administration (FDA) in performing its functions with respect to regenerative medicine; or (2) make grants to fund regulatory research for such purpose.

]]> Regenerative Medicine Promotion Act of 2011 Short Titles as Introduced Regenerative Medicine Promotion Act of 2011 Display Title Regenerative Medicine Promotion Act of 2011 Official Title as Introduced To launch a national strategy to support regenerative medicine through funding for research and commercial development of regenerative medicine products and development of a regulatory environment that enables rapid approval of safe and effective products, and for other purposes. Introduced in House 2011-05-12T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-112hr1862ih/xml/BILLS-112hr1862ih.xml 2011-05-13 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.